Showing results (31-40 of 115) with videos related to
Sort By:
Pageof 12
Cancer Letters|October 13, 2006
Targeting novel and established therapies for non-small cell lung cancerJames Spicer, Simon Chowdhury, Peter HarperJACC. Cardiooncology|August 16, 2021
The TICONC (Ticagrelor-Oncology) Study: Implications of P2Y<sub>12</sub> Inhibition for Metastasis and Cancer-Associated ThrombosisJoy R Wright, Meera Chauhan, Chirag Shah, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2025
Geographic variation in surgery rates among older patients with early (ER positive HER2 negative) breast cancer: Influence of cardiovascular disease and comorbidities: A national registry dataset analysisEmma Crewe, Freya Tyrer, John Deanfield, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trialAlistair Ring, Ivana Sestak, Michael Baum, et al.Breast Cancer Research and Treatment|January 19, 2019
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experienceNicolò Matteo Luca Battisti, Belinda Kingston, Judy King, et al.British Journal of Cancer|September 1, 2017
The prevalence of unmet needs in 625 women living beyond a diagnosis of early breast cancerMarta Capelan, Nicolò Matteo Luca Battisti, Anne McLoughlin, et al.Expert Opinion on Pharmacotherapy|August 10, 2005
Combination therapy versus single agent chemotherapy in non-small cell lung cancerKerry Cheong, James Spicer, Simon Chowdhury, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2014
Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast CancerAlistair Ring, Duncan Wheatley, Helen Hatcher, et al.Clinical Breast Cancer|July 15, 2022
Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-ResistanceAlicia F C Okines, Tazia Irfan, Kabir Mohammed, et al.The Journal of Infectious Diseases|April 24, 2004
Syndromic surveillance for measleslike illnesses in a managed care settingJames D Nordin, Rafael Harpaz, Peter Harper, et al.Pageof 12